NewGenIvf Group Statistics
Total Valuation
NewGenIvf Group has a market cap or net worth of $1.64 million. The enterprise value is $3.30 million.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
NewGenIvf Group has 864,912 shares outstanding.
Current Share Class | 860,807 |
Shares Outstanding | 864,912 |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +185.91% |
Owned by Insiders (%) | 1.01% |
Owned by Institutions (%) | 2.03% |
Float | 856,153 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.30 |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.61 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.17
Current Ratio | 1.17 |
Quick Ratio | 1.06 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.49 |
Financial Efficiency
Return on equity (ROE) is -53.76% and return on invested capital (ROIC) is -27.47%.
Return on Equity (ROE) | -53.76% |
Return on Assets (ROA) | -17.99% |
Return on Invested Capital (ROIC) | -27.47% |
Return on Capital Employed (ROCE) | -135.35% |
Revenue Per Employee | $71,492 |
Profits Per Employee | -$6,903 |
Employee Count | 76 |
Asset Turnover | 1.35 |
Inventory Turnover | 34.83 |
Taxes
Income Tax | -486,706 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.77% in the last 52 weeks. The beta is -0.10, so NewGenIvf Group's price volatility has been lower than the market average.
Beta (5Y) | -0.10 |
52-Week Price Change | -99.77% |
50-Day Moving Average | 4.95 |
200-Day Moving Average | 178.42 |
Relative Strength Index (RSI) | 29.09 |
Average Volume (20 Days) | 491,087 |
Short Selling Information
The latest short interest is 518,211, so 59.91% of the outstanding shares have been sold short.
Short Interest | 518,211 |
Short Previous Month | 92,770 |
Short % of Shares Out | 59.91% |
Short % of Float | 60.53% |
Short Ratio (days to cover) | 0.15 |
Income Statement
In the last 12 months, NewGenIvf Group had revenue of $5.43 million and -$524,643 in losses.
Revenue | 5.43M |
Gross Profit | 1.83M |
Operating Income | -1.16M |
Pretax Income | n/a |
Net Income | -524,643 |
EBITDA | -1.14M |
EBIT | -1.16M |
Earnings Per Share (EPS) | n/a |
Full Income Statement Balance Sheet
The company has $1.53 million in cash and $3.18 million in debt, giving a net cash position of -$1.65 million or -$1.91 per share.
Cash & Cash Equivalents | 1.53M |
Total Debt | 3.18M |
Net Cash | -1.65M |
Net Cash Per Share | -$1.91 |
Equity (Book Value) | -1.48M |
Book Value Per Share | -46.05 |
Working Capital | 452,391 |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$8.26 million and capital expenditures -$53,045, giving a free cash flow of -$8.32 million.
Operating Cash Flow | -8.26M |
Capital Expenditures | -53,045 |
Free Cash Flow | -8.32M |
FCF Per Share | -$9.62 |
Full Cash Flow Statement Margins
Gross margin is 33.62%, with operating and profit margins of -21.36% and -9.66%.
Gross Margin | 33.62% |
Operating Margin | -21.36% |
Pretax Margin | -17.68% |
Profit Margin | -9.66% |
EBITDA Margin | -21.00% |
EBIT Margin | -21.36% |
FCF Margin | n/a |
Dividends & Yields
NewGenIvf Group does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -31.93% |
FCF Yield | -506.11% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on August 4, 2025. It was a reverse split with a ratio of 1:5.
Last Split Date | Aug 4, 2025 |
Split Type | Reverse |
Split Ratio | 1:5 |
Scores
NewGenIvf Group has an Altman Z-Score of 1.86 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.86 |
Piotroski F-Score | 1 |